linagliptin and semaglutide Will oral be a game-changer in the management of type 2 diabetes in primary care? Frontiers | Efficacy and safety

In some adults, Wegovy is also prescribed to reduce the risk of major cardiovascular events when cardiovascular disease is present

Conclusion Understanding the long-term side effects of Ozempic allows patients and healthcare professionals to weigh its powerful benefits against its potential risks

Don't let a gap in medication undo what you've worked hard for

Losing weight can be a transformative journey, offering incredible benefits to your health, confidence, and overall well-being

Upon embarking on your weight loss journey, your doctor will start by 1 : You are generally considered a candidate for GLP-1 therapy if you have a: Body mass index (BMI) of 30kg/m 2 or higher 2 BMI of 27kg/m 2 or higher in the presence of high blood pressure, high cholesterol, type 2 diabetes, sleep apnea, or heart disease 2 Your doctor may prescribe GLP-1 medications at an even lower BMI if you are at a high risk of obesity-related health problems 3

High), those with obesity and obesity-related comorbidities without diabetes (Class III